China NMPA Drug Inspection - Taiji Group Sichuan Nanchong Pharmaceutical Co., Ltd. - Asarum
China NMPA drug inspection for Taiji Group Sichuan Nanchong Pharmaceutical Co., Ltd. published July 31, 2017. Drug: Asarum. The Fujian Province Drug Quality Announcement (Issue 6, 2017, Total Issue 67), published on July 31, 2017, reports on su
One-time purchase from the GKS catalog. Lifetime access in your library. Single documents and full company profiles available. All sales final.
China NMPA drug inspection for Taiji Group Sichuan Nanchong Pharmaceutical Co., Ltd. published July 31, 2017. Drug: Asarum. The Fujian Province Drug Quality Announcement (Issue 6, 2017, Total Issue 67), published on July 31, 2017, reports on su
Access our comprehensive regulatory intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox